Sorry for the split conversation boxes, couldnt add the biomuse screen shot to original post.
Anyways, as read, normal brain mass loss is 5% a decade after the age of 40yrs of age. The biomuse study found MSA pts have a mass reduction of 3-5% at 6 and 12 months. So, again, if they can prove ATH434 can show positive signs of rapidly reducing the speed of brain loss, it may also slow other neurodegenerate brain loss in other diseases such as AD and FA.
- Forums
- ASX - By Stock
- ATH
- Forebrain atrophy in early AD, by Masters et al
Forebrain atrophy in early AD, by Masters et al, page-8
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $71.15K | 17.43M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
101 | 87272775 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 24185511 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
101 | 87272775 | 0.004 |
62 | 57717766 | 0.003 |
15 | 31645515 | 0.002 |
17 | 108320103 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 24185511 | 15 |
0.006 | 22637365 | 20 |
0.007 | 26724705 | 23 |
0.008 | 29046938 | 31 |
0.009 | 17668789 | 11 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online